(RHK) RHÖN-KLINIKUM - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0007042301
RHK: Hospital, Healthcare, Medical, Rehabilitation, Acute Care Services
RHÖN-KLINIKUM Aktiengesellschaft is a prominent healthcare provider in Germany, delivering a comprehensive range of services through its subsidiaries, including in-patient, semi-patient, and outpatient care. The company's network encompasses acute hospitals, medical care centers, and rehabilitation hospitals, catering to diverse patient needs. With a history dating back to 1973, RHÖN-KLINIKUM Aktiengesellschaft has established itself as a key player in the German healthcare landscape, leveraging its expertise to provide high-quality medical services.
As a major healthcare provider, RHÖN-KLINIKUM Aktiengesellschaft operates a significant number of facilities across Germany, offering specialized treatments and therapies. The company's acute hospitals are equipped to handle emergency cases and complex medical conditions, while its medical care centers focus on preventive care, diagnostics, and treatment of various ailments. Additionally, RHÖN-KLINIKUM Aktiengesellschaft's rehabilitation hospitals provide specialized care and therapy to patients recovering from illnesses, injuries, or surgeries, helping them regain their physical and mental strength.
Headquartered in Bad Neustadt an der Saale, Germany, RHÖN-KLINIKUM Aktiengesellschaft is a publicly traded company, listed on the XETRA stock exchange under the ticker symbol RHK. The company's common stock is traded under the ISIN code DE0007042301, and it is classified under the GICS Sub Industry category of Health Care Facilities. For more information about RHÖN-KLINIKUM Aktiengesellschaft, investors and stakeholders can visit the company's website at https://www.rhoen-klinikum-ag.com, which provides detailed insights into its business operations, financial performance, and strategic initiatives.
Additional Sources for RHK Stock
RHK Stock Overview
Market Cap in USD | 957m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception |
RHK Stock Ratings
Growth 5y | -21.8% |
Fundamental | 32.4% |
Dividend | 8.87% |
Rel. Strength Industry | 1325 |
Analysts | - |
Fair Price Momentum | 15.53 EUR |
Fair Price DCF | 12.60 EUR |
RHK Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 71.2% |
RHK Growth Ratios
Growth Correlation 3m | 83.7% |
Growth Correlation 12m | 72.5% |
Growth Correlation 5y | -89.1% |
CAGR 5y | -1.66% |
CAGR/Mean DD 5y | -0.08 |
Sharpe Ratio 12m | 1.16 |
Alpha | 43.06 |
Beta | 0.05 |
Volatility | 44.66% |
Current Volume | 0k |
Average Volume 20d | 2.4k |
As of January 22, 2025, the stock is trading at EUR 14.70 with a total of 0 shares traded.
Over the past week, the price has changed by -0.68%, over one month by +5.76%, over three months by +16.67% and over the past year by +47.74%.
Neither. Based on ValueRay Fundamental Analyses, RHÖN-KLINIKUM is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 32.40 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RHK as of January 2025 is 15.53. This means that RHK is currently overvalued and has a potential downside of 5.65%.
RHÖN-KLINIKUM has no consensus analysts rating.
According to ValueRays Forecast Model, RHK RHÖN-KLINIKUM will be worth about 16.8 in January 2026. The stock is currently trading at 14.70. This means that the stock has a potential upside of +14.08%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 14 | -4.8% |
Analysts Target Price | - | - |
ValueRay Target Price | 16.8 | 14.1% |